Form D · Biotechnology
Oxford Biodynamics PLC
Oxford, X0 · CIK 0001892722
Offering snapshot reported Nov 12, 2021 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2021 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420823
Source: Form D, filed Nov 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexandre Akoulitchev | Director |
| Jon Burrows | Director, Executive |
| Stephen Diggle | Director |
| David Holbrook | Director |
| Paul Stockdale | Director, Executive |
| Matthew Wakefield | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3140 Rowan Place, John Smith Drive Oxford Business Park South
Oxford, X0, OX4 3WB
Oxford, X0, OX4 3WB